Legend of Xiangjiang Tycoon

Finally, the introduction is the most anticipated Hutchison Whampoa Group, and Huo Jianzhuo spoke as the vice president.

"Boss, my colleagues, Hutchison Whampoa Group consists of the following three sectors, Hutchison Property Co., Ltd., Hutchison Port Group Co., Ltd., and Hutchison Pharmaceutical Co., Ltd."

"Hutchison Port Group Co., Ltd. currently operates 135 berths in 27 regions in 15 countries."

"And our Hong Kong International Container Terminal Company is the world's largest private container terminal dealer."

"But the boss was going to take out Hutchison Port Group Co., Ltd. and list it separately."

"At present, we Hutchison Whampoa Group hold 45% of the shares of Hutchison Port Group, and the other shares are in the hands of other small shareholders."

"Last year, the total revenue of Hutchison Port Group Co., Ltd. was 3.55 billion Hong Kong dollars, and the total profit was 2.34 billion Hong Kong dollars!" Huo Jianzuo said.

Huo Jian's words caused an uproar in the office.

The profit of a port group is so high, how can others survive.

But Li Zhiwen knew the inside story, and the reason was the land at the Huangpu Dockyard.

You must know that the Huangpu Dockyard is located in the West Kowloon area. The location is very good. It is very inappropriate as a dock development.

The Huangpu Dockyard is conservatively estimated to be 300,000 feet, and ninety-four commercial and residential buildings can be built.

Of course, the investment in developing the Whampoa Dockyard is not small, conservatively estimated at 3 billion Hong Kong dollars.

In the previous integration, Li Zhiwen asked Huo Jianzhuo to get the land of Huangpu Dockyard.

But it is a pity that those small shareholders united against Li Zhiwen at that time, and Li Zhiwen's shares were not able to achieve the majority.

Although these shareholders are not optimistic about the development of Xiangjiang, they do not want to give up directly.

Li Zhiwen came to think of the empty-handed white wolf to take the land, but practical reasons hindered Li Zhiwen.

Li Zhiwen had no choice but to spend 1.5 billion Hong Kong dollars to buy the land at the Huangpu Dockyard.

This is what Li Zhiwen is buying now. If the market improves, the price of this land may double.

Therefore, 1.5 billion of the profits of more than 2 billion Hong Kong dollars is the money for buying and selling land.

Of course, there are all kinds of people in the office, so I don't know how the two billion Hong Kong dollars came from, which also shocked the people in the office.

"The Hutchison Whampoa Real Estate Company currently has eight properties under construction, four properties under construction, twelve industrial buildings, and the group can collect rents of 90 million Hong Kong dollars a year. There are three industrial buildings under construction, and hoarding There are 17.7 million feet of land, of which the land on Hong Kong Island is more than 4 million feet, and the land hoarded on the Kowloon Peninsula reaches more than 5.5 million feet, and the hoarded land is mainly concentrated in the New Territories. Over 8.2 million feet."

At this time, the development intensity of the New Territories was not enough, so the land in the New Territories that Qi had hoarded did not have much value.

But Li Zhiwen never thought that he would just roll up a sum of money in Hong Kong and leave, so Li Zhiwen can slowly hoard and build slowly. After the construction of Hong Kong Island and Kowloon is bloated, it will naturally develop to the New Territories.

"And Hutchison Real Estate's revenue last year was HK$534 million, and its profit was negative HK$3.137 billion!"

As soon as Huo Jian's words came out, there was another uproar in the conference room.

With a negative profit of 3.1 billion, this can put a duck's egg in everyone's mouth. What kind of company can have so much debt.

Li Zhiwen knew that there were 1.5 billion Hong Kong dollars to buy the Whampoa Dockyard.

But the other 1.6 billion Hong Kong dollars needs Huo Jianzhuo to explain.

"Boss, first of all, during the previous integration, not all companies were wholly-owned, so there were more than 900 million Hong Kong dollars of funds for these."

"The other 700 million Hong Kong dollars is for various materials and labor costs."

"Boss, you also know that the property market in Xiangjiang is very sluggish at this time, and many houses cannot be sold or the prices are too low."

"Before the boss ordered us to continue the construction, so it also led to so many deficits." Huo Jianzhuo explained.

"I understand, let's continue!" Li Zhiwen said.

Huo Jianzuo continued: "Chi-Huang Pharmaceutical Technology Co., Ltd. is mainly based on Mannings Pharmacy. There are 53 Mannings pharmacies under it, with an annual profit of 210 million Hong Kong dollars and 2 million Hong Kong dollars."

"Boss, at this time, the Wanning Pharmacy is mainly based on Western medicine, but I think we should pay more attention to Chinese medicine treatment, which is our national quintessence."

"Tell me!" Li Zhiwen said.

"Boss, first of all, we need to buy a lot of traditional Chinese medicine prescriptions, which is the basis of our important market. At this time, a Japanese company called Tsumura Co., Ltd. is doing it. They buy it from the villagers at a very low price in the north. Ancient prescriptions, even an ancient prescription is only a few Hong Kong dollars." Huo Jianzuo said.

Huo Jian's words evoked Li Zhiwen's memory.

That was when Li Zhiwen's family in the previous life had not gone bankrupt. At that time, Li Zhiwen's younger brother had a serious illness that many hospitals could not handle.

The last hospital in the capital recommended them to go to Japan's Tsumura Pharmaceutical Company to have a look. Maybe there is a solution.

As a result, Father Li took his family to Japan, found Tsumura Pharmaceutical, and finally found a formula in the research institute of Tsumura Pharmaceutical, which cured his brother's illness.

Therefore, Li Zhiwen is very familiar with some things about Tsumura Pharmaceutical, and it can even be said that he is familiar with it.

And the more he knew about Tsumura Pharmaceutical, the more indignant Li Zhiwen became.

Japan Tsumura Co., Ltd., established in 1893, has been committed to the scientific research of Kampo preparations for more than 80 years. With the goal of producing high-quality Kampo products and new drugs, in 1924, Japan's only crude drug research institute was established. "Tsumura Research Institute" and "Tsumura Medicinal Plants"

Tsumura Pharmaceutical, Japan's largest Kampo medicine production and research company, Kampo medicine is Chinese medicine!

Traditional Chinese medicine has a bad reputation in China, and it is often inferior to Western medicine. There are many reasons, such as the quality of medicinal materials, standardized production and pharmaceutical processes, and difficulties in the cultivation of traditional Chinese medicine.

However, in Japan, Kampo medicine is regarded as a good thing for health preservation by the Japanese. Since the introduction of traditional Chinese medicine in the fifth and sixth centuries, the Japanese have gradually formed the tradition of taking traditional Chinese medicine. , it treasures precious medicinal materials such as agarwood 1200 years ago.

The Japanese believe that Kampo medicines can improve physical fitness, and they believe Kampo medicines can cure pre-existing diseases. They are mainly used to prevent and treat lifestyle diseases such as hypertension and hyperlipidemia, as well as post-operative adjuvant therapy.

In Japan, 89% of doctors prescribe Kampo prescription drugs, which shows the popularity of Kampo medicine in Japan.

Gu Yan It is embarrassing that Japan has established a modern pharmaceutical standard for traditional Chinese medicine before China.

On the contrary, when one thinks about the status of Chinese medicine in China, one can't help but hate that iron is not steel.

Even many domestic people traveled all the way to Japan to buy Kampo medicines to bring back home, but they didn't know that Japanese Kampo medicines, not only the prescriptions, but also the raw materials of medicines, mostly came from China.

The things hidden here will slap some domestic people in the face.

After the establishment of diplomatic relations between China and Japan, the Kampo medicine company headed by Tsumura Pharmaceuticals began to send people into the country to collect ancient Chinese medicine prescriptions from all over the country at extremely low prices. These are the essences that have been handed down for thousands of years. Hundreds or even dozens of cabbage prices to buy.

In later generations, more than 200 kinds of Kampo medicines, including prescription drugs and non-prescription drugs, produced by Japan's Tsumura Pharmaceutical Co., Ltd. accounted for more than 80% of the market share.

Most of the prescriptions for these drugs come from China. When domestic pharmaceutical companies want to produce these drugs, they must pay protection fees to Tsumura Pharmaceuticals. The key is that some important drugs are not authorized to domestic pharmaceutical companies.

In addition, there is another data that is extremely dazzling, and that is the most critical medicinal material planting base of traditional Chinese medicine.

Japan has few species of small creatures, while the mainland has vast resources.

Many Kampo medicines in Japan have to import raw materials from China. In order to solve this drawback, Tsumura Pharmaceuticals thought of building a GAP (Quality Management Practice for Chinese Herbal Medicine) medicinal material planting base directly in China to control the quality from the source.

Tsumura Pharmaceuticals alone has more than 70 GAP bases in Qianzhou and Guangxi Province. In contrast, Tongrentang is an important company with the most GPA bases in China, but only eight in later generations.

How big is the gap between the eight and the seventy? From the source, it has been left far behind by others!

They use domestic medicinal farmers and bases to grow medicinal materials for them, and use the prescriptions bought from China at the price of cabbage. In the end, they make domestic money in turn. Japan also uses traditional Chinese medicine to apply for the world's intangible cultural heritage.

All of this, how insidious! How shameless! It made the people in the country angry!

And Tsumura Pharmaceutical, the largest Kampo medicine company in Japan, is the culprit.

However, there is no way to do it. In this era, there is no experience in China, and the Japanese are still crossing the river by feeling the stones. The Japanese have no intention of calculating, and they are simply unable to guard against it.

So if Li Zhiwen wants to enter the traditional Chinese medicine industry, Tsumura Pharmaceutical is a strong opponent.

"Jianzuo, can you buy Tsumura Co., Ltd.?" Li Zhiwen asked.

Li Zhiwen decided to solve Tsumura's opponent directly from the source.

If you buy it, you will be able to eat the heritage accumulated by Tsumura Pharmaceutical in the past 80 years, and you will also be able to take back the advantages that Tsumura Pharmaceutical has taken from China in the past few years!

This is the best way to recover the loss, and at the same time it can destroy a powerful enemy.

Otherwise, there is a Japanese market for Tsumura Pharmaceutical Company to take root and grow, and the domestic market is still immature. Even if Li Zhiwen establishes a new company, it will be difficult for him to compete with Tsumura Pharmaceutical Company in a short period of time.

According to the original trajectory, even in 2000, the annual turnover of Tsumura Pharmaceutical Company exceeded the domestic sales of Chinese patent medicines for the whole year by 19%.

When Li Zhiwen went to Japan to seek medical treatment, the turnover of Tsumura Pharmaceutical Company was still ahead of the overall domestic sales of traditional Chinese medicine.

If there was no external stimulus, Li Zhiwen would have to endure for more than 20 years and monopolize the sales of Chinese patent medicines in the whole country. Only then would it be possible to fight against Tsumura Pharmaceuticals, or to cooperate with the government at that time, but that was a last resort.

For more than 20 years, it can vary!

Just using external force to change requires a lot of effort!

Huo Jianzuo was frightened by Li Zhiwen's jumping thinking. After thinking for a while, he said, "Boss, I personally think it is difficult. This is not a question of money, but also involves the dispute between Chinese and Western medicine."

"Don't look at the fact that Tsumura Pharmaceutical is now No. 1 in Japan. The Japanese people also recognize Kampo medicine, but it is still recovering."

"During the Meiji Restoration, Japan fully learned from the West and introduced a bill to abolish traditional Chinese medicine. Only a few senior Chinese medicine practitioners gritted their teeth and called for the restart of traditional Chinese medicine."

"It was not until after 1945, when Japan began to step into a modern country, that the value of Chinese medicine was discovered by more and more people, and the people learned Chinese medicine spontaneously, and then the government repealed the Act of the Meiji Restoration period, and Chinese medicine and Kampo medicine were revived. vitality."

"Moreover, over the past 80 years, Tsumura Pharma's shareholders have changed many times. Many of the current shareholders are Chinese medicine research institutes or medical schools. Tsumura Pharma has become the company that succeeded in their experimental research and expanded their influence. exist."

"It also involves the dispute between Chinese and Western medicine. Tsumura Pharmaceutical's long-term development strategy has already been set, and this cannot be solved by money."

"If you want to acquire it, it is very difficult."

Li Zhiwen frowned, this was the result Li Zhiwen didn't want to hear.

If it was a lack of money, Li Zhiwen would solve it, but the rest would be very difficult.

Tsumura Pharmaceutical has involved ideological and industrial struggles. For those institutions and idealistic people, money is secondary.

He is very clear that money is not a panacea, and it may be able to solve 99% of the problems, but for a very small number of idealists, money is just a tool they use to achieve their goals~www.wuxiaspot.com~The capitalist is for this This kind of people is love and hate, love because they need to research technology, hate because many of them are inaccessible, making capitalists' biggest weapon, capital, useless.

"Then how to remedy it?" Li Zhiwen asked.

Since you can't buy it, you have to start somewhere else.

"Boss, I think we still have to start from other aspects."

"The future of Chinese medicine and Chinese medicine other than Japan now lies not in market promotion, but in inheritance and cultivation of Chinese herbal medicine. The latter two have problems."

"Many old Chinese medicine practitioners have passed away in the past ten years. Now there are only about 15 Chinese medicine practitioners who are really capable in Xiangjiang. Among them, the inheritance of five of them is unstable, and future generations are reluctant to learn."

"I don't know the situation in Southeast Asia very well, but it is conservatively estimated that there are still more than a dozen old Chinese medicine practitioners, and the most reserved ones are in the east."

"The other is the cultivation of Chinese herbal medicine. There is only one Chinese herbal medicine trading market in Xiangjiang. It was good more than ten years ago, and the quality is guaranteed. Now the quality of Chinese herbal medicine has generally declined, and the good and the bad are mixed. I didn't need to worry about buying medicine before. Now every time I buy medicine I have to choose them myself, or else I won't be able to achieve the efficacy of the medicine, and I will harm others and myself."

"According to this trend, if there is no change, traditional Chinese medicine will gradually decline, and traditional Chinese medicine will be almost the same."

​​

Please remember the first domain name of this book: . Mobile version update fastest URL: